The Patent Finder

CTXT Pty Ltd.

18 patents currently held · Updated Nov 21, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Tetrahydroisoquinolines as PRMT5 inhibitors (US 10,421,743) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 2 fees due Jun 3 to 30, 2027 · next Jun 3
  • 2 fees due Aug 4 to 27, 2027 · next Aug 4
  • 1 fee due Nov 12, 2027
    The maintenance fee for Tetrahydroisoquinoline derived PRMT5-inhibitors (US 10,647,708) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,005,792Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors
In force
 · USPTO record
In forceUSPTO record
US 10,494,376Tetrahydroisoquinoline derived PRMT5-inhibitors
In force
 · USPTO record
In forceUSPTO record
US 10,647,708Tetrahydroisoquinoline derived PRMT5-inhibitors
In force
 · USPTO record
In forceUSPTO record
US 10,421,743Tetrahydroisoquinolines as PRMT5 inhibitors
In force
 · USPTO record
In forceUSPTO record
US 10,519,1673-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathies
In force
 · USPTO record
In forceUSPTO record
US 10,550,096Tetrahydroisoquinolines as PRMT5 inhibitors
In force
 · USPTO record
In forceUSPTO record
US 11,028,1013-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathies
In force
 · USPTO record
In forceUSPTO record
US 10,787,434Benzopiperdine derivatives and their use in the treatment of cancer and hemoglobinopathies
In force
 · USPTO record
In forceUSPTO record
US 10,961,256PRMT5 inhibitors
In force
 · USPTO record
In forceUSPTO record
US 10,745,380Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathies
In force
 · USPTO record
In forceUSPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
Also on record, not counted in the 18: 2 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 abandoned · 4 no status recorded

Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/210,024Nitrogen-Linked Benzisoxazole Sulfonamide DerivativesMay 16, 2025Abandoned
18/950,782Nov 18, 2024No status recorded
18/903,849Nitrogen-Linked Benzisoxazole Sulfonamide DerivativesOct 1, 2024Pending
18/394,624Dec 22, 2023No status recorded
18/162,250Jan 31, 2023No status recorded
16/446,868Benzisoxazole Sulfonamide DerivativesJun 20, 2019Abandoned
16/642,290Aug 31, 2018No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited